The Ambry CARE Program

Comprehensive Assessment, risk & education

Identify women at increased risk for breast cancer earlier

End-to-End Solution to Identify High-Risk Women

Arrow Identification Identification

Using Ambry's High-Risk Screening Tool

Arrow Pre-test education Pre-test education

How genetic testing can guide early detection and prevention

Arrow Genetic testing Genetic testing

Ordered through Ambry for qualified individuals

Arrow Results Results

Patient test results delivered to ordering provider

Arrow Post-test counseling Post-test counseling

Genetic counseling to review next steps

Documentation Documentation

Increase quality, decrease liability assessment

Benefits of the Ambry CARE Program

Provide personalized cancer risk information

Identify at-risk family members

Make recommendations for increased screening

Integrate seamlessly into your existing workflow

Genetic Testing and Family History Assessment to Better Identify High-Risk Women

Lifetime breast cancer risk: 12% in the general population; 20% with a family history of breast cancer; 45-87% women with BRCA1/2 or other mutation

High-Risk Women Are Being Missed

80% of women with a history of breast cancer and who met criteria did not receive genetic testing.3

Four out of five women with a history of breast cancer and met testing criteria did not receive genetic testing Four out of five women with a history of breast cancer and met testing criteria did not receive genetic testing

1. Engel C, Fischer C. Breast cancer risks and risk prediction models. Breast Care (Basel). 2014;10(1):7-12.
2. Adapted from American College of Radiology Practice Guidelines. https://www.acr.org/-/media/ACR/Files/Practice-Parameters/mr-contrast-breast.pdf
3. Childers CP, Childers KK, Maggard-Gibbons M, Macinko J. National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer. J Clin Oncol. 2017;35(34):3800-3806

Search Results

Start your search...